PDF(Pubmed)
Abstract：
BACKGROUND: Avoidant/restrictive food intake disorder (ARFID) is a serious, albeit under-researched, feeding or eating disorder. This exploratory study utilized data from adult respondents to the National Eating Disorders Association online eating disorder screen to validate items assessing the presence of ARFID and examine the prevalence, clinical characteristics, and correlates of a positive ARFID screen.
METHODS: Among 50,082 adult screen respondents between January 2022 and January 2023, the prevalence of a positive ARFID screen was calculated. Chi-square tests and t-tests compared demographics, eating disorder attitudes and behaviors, suicidal ideation, current eating disorder treatment status, and eating disorder treatment-seeking intentions between respondents with possible ARFID and other eating disorder diagnostic and risk categories. Clinical characteristics of respondents with possible ARFID were also examined.
RESULTS: 2378 (4.7%) adult respondents screened positive for ARFID. Respondents with possible ARFID tended to be younger, male, and have lower household income, and were less likely to be White and more likely to be Hispanic/Latino than most other diagnostic/risk groups. They had lower weight/shape concerns and eating disorder behaviors than most other diagnoses and higher BMI than those with AN. 35% reported suicidal ideation, 47% reported intentions to seek treatment for an eating disorder, and 2% reported currently being in treatment. The most common clinical feature of ARFID was lack of interest in eating (80%), followed by food sensory avoidance (55%) and avoidance of food due to fear of aversive consequences (31%).
CONCLUSIONS: Findings from this study indicated that ARFID was prevalent among adult screen respondents and more common among individuals who were younger, male, non-White, Hispanic, and lower income relative to those with other eating disorders, at risk for an eating disorder, or at low risk. Individuals with possible ARFID frequently reported suicidal ideation and were rarely in treatment for an eating disorder. Further research is urgently needed to improve advances in the assessment and treatment of ARFID and improve access to care in order to prevent prolonged illness duration.
This study examined data from adult respondents to a publicly available online eating disorders screen adult to examine the prevalence, clinical characteristics, and correlates of a positive ARFID screen. 4.7% of respondents screened positive for ARFID. A positive ARFID screen was more common among respondents who were younger, male, non-White, Hispanic, and lower income relative to those in other eating disorder diagnostic/risk categories. Respondents with possible ARFID frequently reported suicidal ideation and were rarely in treatment for an eating disorder. Lack of interest in food or eating was the most common clinical feature among those with possible ARFID.
METHODS: Among 50,082 adult screen respondents between January 2022 and January 2023, the prevalence of a positive ARFID screen was calculated. Chi-square tests and t-tests compared demographics, eating disorder attitudes and behaviors, suicidal ideation, current eating disorder treatment status, and eating disorder treatment-seeking intentions between respondents with possible ARFID and other eating disorder diagnostic and risk categories. Clinical characteristics of respondents with possible ARFID were also examined.
RESULTS: 2378 (4.7%) adult respondents screened positive for ARFID. Respondents with possible ARFID tended to be younger, male, and have lower household income, and were less likely to be White and more likely to be Hispanic/Latino than most other diagnostic/risk groups. They had lower weight/shape concerns and eating disorder behaviors than most other diagnoses and higher BMI than those with AN. 35% reported suicidal ideation, 47% reported intentions to seek treatment for an eating disorder, and 2% reported currently being in treatment. The most common clinical feature of ARFID was lack of interest in eating (80%), followed by food sensory avoidance (55%) and avoidance of food due to fear of aversive consequences (31%).
CONCLUSIONS: Findings from this study indicated that ARFID was prevalent among adult screen respondents and more common among individuals who were younger, male, non-White, Hispanic, and lower income relative to those with other eating disorders, at risk for an eating disorder, or at low risk. Individuals with possible ARFID frequently reported suicidal ideation and were rarely in treatment for an eating disorder. Further research is urgently needed to improve advances in the assessment and treatment of ARFID and improve access to care in order to prevent prolonged illness duration.
This study examined data from adult respondents to a publicly available online eating disorders screen adult to examine the prevalence, clinical characteristics, and correlates of a positive ARFID screen. 4.7% of respondents screened positive for ARFID. A positive ARFID screen was more common among respondents who were younger, male, non-White, Hispanic, and lower income relative to those in other eating disorder diagnostic/risk categories. Respondents with possible ARFID frequently reported suicidal ideation and were rarely in treatment for an eating disorder. Lack of interest in food or eating was the most common clinical feature among those with possible ARFID.
摘要：
背景：避免/限制性食物摄入障碍（ARFID）是一种严重的，尽管研究不足，进食或进食障碍。这项探索性研究利用了全国饮食失调协会在线饮食失调筛查的成人受访者的数据来验证评估ARFID存在的项目并检查患病率。临床特征,与ARFID阳性筛选相关。
方法：在2022年1月至2023年1月的50,082名成人筛查受访者中，计算了ARFID筛查阳性的患病率。卡方检验和t检验比较人口统计，饮食失调的态度和行为，自杀意念,目前饮食失调治疗现状，以及可能有ARFID和其他饮食失调诊断和风险类别的受访者之间寻求饮食失调治疗的意图。还检查了可能患有ARFID的受访者的临床特征。
结果：2378（4.7%）成人受访者ARFID筛查呈阳性。可能有ARFID的受访者往往更年轻，男性,家庭收入较低，与大多数其他诊断/风险组相比，白人和西班牙裔/拉丁裔的可能性较小。与大多数其他诊断相比，他们的体重/形状问题和饮食失调行为较低，而BMI高于AN患者。35%的人报告有自杀意念,47%的人表示有意寻求饮食失调的治疗，2%报告目前正在接受治疗。ARFID最常见的临床特征是对饮食缺乏兴趣（80％），其次是避免食物感觉（55％）和由于害怕厌恶后果而避免食物（31％）。
结论：这项研究的结果表明，ARFID在成人屏幕受访者中普遍存在，在年轻的人群中更常见，男性,非白色,西班牙裔,与其他饮食失调的人相比，收入较低，有进食障碍的风险，或低风险。具有可能的ARFID的个体经常报告自杀意念，并且很少接受饮食失调的治疗。迫切需要进一步研究，以改善ARFID评估和治疗的进展，并改善获得护理的机会，以防止疾病持续时间延长。
这项研究检查了成人受访者的数据，以公开的在线饮食失调筛查成人，以检查患病率，临床特征,与ARFID阳性筛选相关。4.7%的受访者对ARFID筛查呈阳性。积极的ARFID屏幕在年轻的受访者中更为常见，男性,非白色,西班牙裔,与其他饮食失调诊断/风险类别的人相比，收入较低。可能有ARFID的受访者经常报告自杀意念，很少接受饮食失调的治疗。在可能患有ARFID的患者中，对食物或饮食缺乏兴趣是最常见的临床特征。
方法：在2022年1月至2023年1月的50,082名成人筛查受访者中，计算了ARFID筛查阳性的患病率。卡方检验和t检验比较人口统计，饮食失调的态度和行为，自杀意念,目前饮食失调治疗现状，以及可能有ARFID和其他饮食失调诊断和风险类别的受访者之间寻求饮食失调治疗的意图。还检查了可能患有ARFID的受访者的临床特征。
结果：2378（4.7%）成人受访者ARFID筛查呈阳性。可能有ARFID的受访者往往更年轻，男性,家庭收入较低，与大多数其他诊断/风险组相比，白人和西班牙裔/拉丁裔的可能性较小。与大多数其他诊断相比，他们的体重/形状问题和饮食失调行为较低，而BMI高于AN患者。35%的人报告有自杀意念,47%的人表示有意寻求饮食失调的治疗，2%报告目前正在接受治疗。ARFID最常见的临床特征是对饮食缺乏兴趣（80％），其次是避免食物感觉（55％）和由于害怕厌恶后果而避免食物（31％）。
结论：这项研究的结果表明，ARFID在成人屏幕受访者中普遍存在，在年轻的人群中更常见，男性,非白色,西班牙裔,与其他饮食失调的人相比，收入较低，有进食障碍的风险，或低风险。具有可能的ARFID的个体经常报告自杀意念，并且很少接受饮食失调的治疗。迫切需要进一步研究，以改善ARFID评估和治疗的进展，并改善获得护理的机会，以防止疾病持续时间延长。
这项研究检查了成人受访者的数据，以公开的在线饮食失调筛查成人，以检查患病率，临床特征,与ARFID阳性筛选相关。4.7%的受访者对ARFID筛查呈阳性。积极的ARFID屏幕在年轻的受访者中更为常见，男性,非白色,西班牙裔,与其他饮食失调诊断/风险类别的人相比，收入较低。可能有ARFID的受访者经常报告自杀意念，很少接受饮食失调的治疗。在可能患有ARFID的患者中，对食物或饮食缺乏兴趣是最常见的临床特征。
